BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7197975)

  • 1. Pharmacokinetics of amezinium in man.
    Traut M; Brode E
    Arzneimittelforschung; 1981; 31(9a):1605-15. PubMed ID: 7197975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of amezinium in rat and dog.
    Traut M; Brode E; Neumann B; Kummer H
    Arzneimittelforschung; 1981; 31(9a):1594-604. PubMed ID: 7197974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absolute bioavailability of amezinium. A cross-over study after i.v. and p.o. application.
    Kaumeier S; Kehrhahn OH; Morgenthaler H; Neugebauer G
    Arzneimittelforschung; 1981; 31(9a):1653-7. PubMed ID: 7197980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of ameziniummetilsulfate in man. Single and repetitive oral administration of a therapeutically effective dose.
    Brode E; Hollmann M; Vollgraf C
    Arzneimittelforschung; 1983; 33(10):1491-7. PubMed ID: 6686052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic effects of amezinium in man.
    Wilsmann K; Neugebauer G; Kessel R; Lang E
    Arzneimittelforschung; 1981; 31(9a):1638-46. PubMed ID: 7197978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fate of amezinium in humans and animals.
    Traut M; Kummer H; Brode E
    Arzneimittelforschung; 1981; 31(9a):1616-22. PubMed ID: 7197976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of amezinium, a novel antihypotensive drug. VI. Effect on central nervous functions.
    Teschendorf HJ; Kretzschmar R; Kreiskott H; Weifenbach H
    Arzneimittelforschung; 1981; 31(9a):1580-8. PubMed ID: 7197973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of amezinium in humans during passive upright tilt in comparison with norfenefrine and dihydroergotamine.
    Wilsmann K; Neugebauer G; Kessel R; Lang E
    Arzneimittelforschung; 1981; 31(9a):1647-52. PubMed ID: 7197979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man.
    Ahr HJ; Boberg M; Brendel E; Krause HP; Steinke W
    Arzneimittelforschung; 1997 Jun; 47(6):734-45. PubMed ID: 9239452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of amezinium, a novel antihypotensive drug. IV. Biochemical investigations of the mechanism of action.
    Traut M; Brode E; Hoffmann HD
    Arzneimittelforschung; 1981; 31(9a):1566-74. PubMed ID: 7197971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of 3H-bamethan in humans].
    Hengstmann JH; Steinkamp B
    Arzneimittelforschung; 1981; 31(5):843-8. PubMed ID: 6115653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic fate of exogenous chondroitin sulfate in man.
    Conte A; de Bernardi M; Palmieri L; Lualdi P; Mautone G; Ronca G
    Arzneimittelforschung; 1991 Jul; 41(7):768-72. PubMed ID: 1772467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of amezinium in body fluids.
    Traut M; Morgenthaler H; Brode E
    Arzneimittelforschung; 1981; 31(9a):1589-93. PubMed ID: 7030355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of AR-L 115 BS in rhesus monkeys (author's transl)].
    Mierau J
    Arzneimittelforschung; 1981; 31(1a):221-5. PubMed ID: 7195226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative review of the pharmacokinetics of boric acid in rodents and humans.
    Murray FJ
    Biol Trace Elem Res; 1998; 66(1-3):331-41. PubMed ID: 10050928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating mass balance for inhaled drugs in humans: an example with a VLA-4 antagonist, IVL745.
    Rohatagi S; Shah B; Zhang J; Zeng Z; Kirkesseli S; Jensen BK
    J Clin Pharmacol; 2004 Apr; 44(4):348-58. PubMed ID: 15051741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption, disposition, and metabolism of trans-methyl styryl ketone in female B6C3F1 mice.
    Sauer JM; Bao J; Smith RL; Kuester RK; Mayersohn M; Sipes IG
    Drug Metab Dispos; 1997 Oct; 25(10):1184-90. PubMed ID: 9321522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
    Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
    J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.